SCHEMBL13070710

SCHEMBL13070710

Bc1ccc(C(C)(N)C(=O)OCC)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.40
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 2/20 0.40
ABCB11 O95342 1/20 0.40
HTR2A P28223 1/20 0.40
PMP22 Q01453 1/20 0.40
PPARA Q07869 1/20 0.40
PIN1 Q13526 1/20 0.38
MMP8 P22894 1/20 0.37
CNR2 P34972 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 3/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
FBP1 P09467 1/20 0.35
MAOA P21397 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8907388 0.86 CNR2 (0.44) TSHRCYP1A2CYP3A4ABCB11HTR2A
SCHEMBL6135476 0.83 NPSR1 (0.50) TSHRCYP1A2CYP3A4ABCB11HTR2A
SCHEMBL2490473 0.83 CYP3A4 (0.58) TSHRCYP1A2CYP3A4ABCB11HTR2A
SCHEMBL6135621 0.83 NPSR1 (0.50) TSHRCYP1A2CYP3A4ABCB11HTR2A
SCHEMBL204187 0.83 NPSR1 (0.50) TSHRCYP1A2CYP3A4ABCB11HTR2A
SCHEMBL27731921 0.83 PIN1 (0.51) TSHRPIN1MMP8SMN1; SMN2MAPT
SCHEMBL1455978 0.83 PIN1 (0.51) TSHRPIN1MMP8SMN1; SMN2MAPT
SCHEMBL27752471 0.83 PIN1 (0.51) TSHRPIN1MMP8SMN1; SMN2MAPT
SCHEMBL1509089 0.82 L3MBTL1 (0.51) TSHRCYP1A2CYP3A4ABCB11HTR2A
SCHEMBL1972148 0.82 L3MBTL1 (0.51) TSHRCYP1A2CYP3A4ABCB11HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 WO disclosed